Securing the retatrutide compound in the USA currently presents a difficulty as it's not yet approved for widespread public sale . Clinicians participating in research studies may be providing it, but access is limited to those enrolled. Independent pharmacies , operating under specific permits , *might* offer compounded versions, but quality can b